Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC

Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC ( Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA )
26 Apr 2023

Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours

Dr Jason Luke - University of Pittsburgh, Pittsburgh, USA
Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours ( Dr Jason Luke - University of Pittsburgh, Pittsburgh, USA )
26 Apr 2023

Does the mind matter in cancer? Experiences of Psycho-oncology from a tertiary cancer centre in South Asia

Dr Soumitra Datta - Tata Medical Center, Kolkata, India
Does the mind matter in cancer? Experiences of Psycho-oncology from a tertiary cancer centre in South Asia ( Dr Soumitra Datta - Tata Medical Center, Kolkata, India )
25 Apr 2023

Challenge mission to improve access to quality cancer care

Thet Ko Aung - City Cancer Challenge, Yangon, Myanmar
Challenge mission to improve access to quality cancer care ( Thet Ko Aung - City Cancer Challenge, Yangon, Myanmar )
25 Apr 2023

Choosing Wisely: An important step in the right direction

Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines
Choosing Wisely: An important step in the right direction ( Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines )
25 Apr 2023

Cancer situation in Cambodia

Dr Kol Hero - Ministry of Health, Phnom Penh, Cambodia
Cancer situation in Cambodia ( Dr Kol Hero - Ministry of Health, Phnom Penh, Cambodia )
25 Apr 2023

VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers

Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023

Childhood cancer: The surprising scientific facts

Dr Mlis Ratha - Calmette Hospital, Phnom Penh, Cambodia
Childhood cancer: The surprising scientific facts ( Dr Mlis Ratha - Calmette Hospital, Phnom Penh, Cambodia )
25 Apr 2023

Current and future status of cancer care in Calmette Hospital

Dr Rath Beauta - Calmette Hospital, Phnom Penh, Cambodia
Current and future status of cancer care in Calmette Hospital ( Dr Rath Beauta - Calmette Hospital, Phnom Penh, Cambodia )
25 Apr 2023

Choosing Wisely in medical oncology

Dr Omar AbdiHamid - Garissa Cancer Center, Garissa, Kenya
Choosing Wisely in medical oncology ( Dr Omar AbdiHamid - Garissa Cancer Center, Garissa, Kenya )
25 Apr 2023

To avoid unnecessary second surgery in differentiated thyroid cancer

Dr Thou Sarameth - Calmette Hospital, Phnom Penh, Cambodia
To avoid unnecessary second surgery in  differentiated thyroid cancer ( Dr Thou Sarameth - Calmette Hospital, Phnom Penh, Cambodia )
25 Apr 2023

Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours

Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023